Silent metastasis in metastatic castrate-resistant prostate cancer: a collection of two case reports

被引：0

作者：

De Felice, Francesca ^{[1
]}

Vitti, Elisa ^{[1
]}

Cattaneo, Carlo Guglielmo ^{[1
]}

Tomaciello, Miriam ^{[1
]}

Marampon, Francesco ^{[1
]}

Musio, Daniela ^{[1
]}

Gaudino, Chiara ^{[2
]}

Minniti, Giuseppe ^{[1
]}

机构：

[1] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, AOU Policlin Umberto I, Radiat Oncol, Rome, Italy

[2] AOU Policlin Umberto I, Dept Neuroradiol, Rome, Italy

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2025年 / 43卷 / 06期

关键词：

Prostate cancer; PSA; PSA discordance; ARPI; metastasis; castrate-resistant; case report; ENZALUTAMIDE; MEN;

D O I：

10.1016/j.urolonc.2024.10.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Treatment monitoring in metastatic castrate-resistant prostate cancer has become a hot topic in the androgen receptor pathway inhibitors (ARPIs) era. Patients without increase in their PSA level at the time of imaging progression are not a rare phenomenon. What is the best monitoring strategy in asymptomatic cases represents a salient question. Here we presented 2 case reports involving men with metastatic castration-resistant prostate cancer who experienced disease progression without the anticipated increase in PSA levels. Our 2 cases show that imaging beyond standard PSA determination should be incorporate to monitor disease progression in patients with metastatic castrate-resistant prostate cancer even in the context of an undetectable PSA. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

引用

页码：399.e9 / 399.e13

页数：5

共 17 条

[1] ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J].

Armstrong, Andrew J. ;

Szmulewitz, Russell Z. ;

Petrylak, Daniel P. ;

Holzbeierlein, Jeffrey ;

Villers, Arnauld ;

Azad, Arun ;

Alcaraz, Antonio ;

Alekseev, Boris ;

Iguchi, Taro ;

Shore, Neal D. ;

Rosbrook, Brad ;

Sugg, Jennifer ;

Baron, Benoit ;

Chen, Lucy ;

Stenzl, Arnulf .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) :2974-+

[2] Enzalutamide in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study [J].

Beer, Tomasz M. ;

Armstrong, Andrew J. ;

Rathkopf, Dana ;

Loriot, Yohann ;

Sternberg, Cora N. ;

Higano, Celestia S. ;

Iversen, Peter ;

Evans, Christopher P. ;

Kim, Choung-Soo ;

Kimura, Go ;

Miller, Kurt ;

Saad, Fred ;

Bjartell, Anders S. ;

Borre, Michael ;

Mulders, Peter ;

Tammela, Teuvo L. ;

Parli, Teresa ;

Sari, Suha ;

van Os, Steve ;

Theeuwes, Ad ;

Tombal, Bertrand .

EUROPEAN UROLOGY, 2017, 71 (02) :151-154

[3] Aggressive Variants of Castration-Resistant Prostate Cancer [J].

Beltran, Himisha ;

Tomlins, Scott ;

Aparicio, Ana ;

Arora, Vivek ;

Rickman, David ;

Ayala, Gustavo ;

Huang, Jiaoti ;

True, Lawrence ;

Gleave, Martin E. ;

Soule, Howard ;

Logothetis, Christopher ;

Rubin, Mark A. .

CLINICAL CANCER RESEARCH, 2014, 20 (11) :2846-2850

[4] Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL [J].

Bryce, A. H. ;

Alumkal, J. J. ;

Armstrong, A. ;

Higano, C. S. ;

Iversen, P. ;

Sternberg, C. N. ;

Rathkopf, D. ;

Loriot, Y. ;

de Bono, J. ;

Tombal, B. ;

Abhyankar, S. ;

Lin, P. ;

Krivoshik, A. ;

Phung, D. ;

Beer, T. M. .

PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (02) :221-227

[5] Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study [J].

Chi, Kim N. ;

Chowdhury, Simon ;

Bjartell, Anders ;

Byung Ha Chung ;

Gomes, Andrea J. Pereira de Santana ;

Given, Robert ;

Juarez, Alvaro ;

Merseburger, Axel S. ;

Ozguroglu, Mustafa ;

Uemura, Hirotsugu ;

Ye, Dingwei ;

Brookman-May, Sabine ;

Mundle, Suneel D. ;

McCarthy, Sharon A. ;

Larsen, Julie S. ;

Sun, Weili ;

Bevans, Katherine B. ;

Zhang, Ke ;

Bandyopadhyay, Nibedita ;

Agarwal, Neeraj .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) :2294-+

[6] Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer [J].

Davis, Ian D. ;

Martin, Andrew J. ;

Stockler, Martin R. ;

Begbie, Stephen ;

Chi, Kim N. ;

Chowdhury, Simon ;

Coskinas, Xanthi ;

Frydenberg, Mark ;

Hague, Wendy E. ;

Horvath, Lisa G. ;

Joshua, Anthony M. ;

Lawrence, Nicola J. ;

Marx, Gavin ;

McCaffrey, John ;

McDermott, Ray ;

McJannett, Margaret ;

North, Scott A. ;

Parnis, Francis ;

Parulekar, Wendy ;

Pook, David W. ;

Reaume, M. Neil ;

Sandhu, Shahneen K. ;

Tan, Alvin ;

Tan, T. Hsiang ;

Thomson, Alastair ;

Tu, Emily ;

Vera-Badillo, Francisco ;

Williams, Scott G. ;

Yip, Sonia ;

Zhang, Alison Y. ;

Zielinski, Robert R. ;

Sweeney, Christopher J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) :121-131

[7] Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer [J].

Fizazi, Karim ;

Shore, Neal ;

Tammela, Teuvo L. ;

Ulys, Albertas ;

Vjaters, Egils ;

Polyakov, Sergey ;

Jievaltas, Mindaugas ;

Luz, Murilo ;

Alekseev, Boris ;

Kuss, Iris ;

Kappeler, Christian ;

Snapir, Amir ;

Sarapohja, Toni ;

Smith, Matthew R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13) :1235-1246

[8] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer [J].

Fizazi, Karim ;

NamPhuong Tran ;

Fein, Luis ;

Matsubara, Nobuaki ;

Rodriguez-Antolin, Alfredo ;

Alekseev, Boris Y. ;

Ozguroglu, Mustafa ;

Ye, Dingwei ;

Feyerabend, Susan ;

Protheroe, Andrew ;

De Porre, Peter ;

Kheoh, Thian ;

Park, Youn C. ;

Todd, Mary B. ;

Chi, Kim N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :352-360

[9] Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 [J].

Gillessen, Silke ;

Bossi, Alberto ;

Davis, Ian D. ;

de Bono, Johann ;

Fizazi, Karim ;

James, Nicholas D. ;

Mottet, Nicolas ;

Shore, Neal ;

Small, Eric ;

Smith, Matthew ;

Sweeney, Christopher J. ;

Tombal, Bertrand ;

Antonarakis, Emmanuel S. ;

Aparicio, Ana M. ;

Armstrong, Andrew J. ;

Attard, Gerhardt ;

Beer, Tomasz M. ;

Beltran, Himisha ;

Bjartell, Anders ;

Blanchard, Pierre ;

Briganti, Alberto ;

Bristow, Rob G. ;

Bulbul, Muhammad ;

Caffo, Orazio ;

Castellano, Daniel ;

Castro, Elena ;

Cheng, Heather H. ;

Chi, Kim N. ;

Chowdhury, Simon ;

Clarke, Caroline S. ;

Clarke, Noel ;

Daugaard, Gedske ;

De Santis, Maria ;

Duran, Ignacio ;

Eeles, Ross ;

Efstathiou, Eleni ;

Efstathiou, Jason ;

Ekeke, Onyeanunam Ngozi ;

Evans, Christopher P. ;

Fanti, Stefano ;

Feng, Felix Y. ;

Fonteyne, Valerie ;

Fossati, Nicola ;

Frydenberg, Mark ;

George, Dan ;

Gleave, Martin ;

Gravis, Gwenaelle ;

Halabi, Susan ;

Heinrich, Daniel ;

Herrmann, Ken .

EUROPEAN JOURNAL OF CANCER, 2023, 185 :178-215

[10] Real-world analysis of metastatic prostate cancer demonstrates increased frequency of PSA-imaging discordance with visceral metastases and upfront ARAT/docetaxel therapy [J].

Hara, Takuto ;

Terakawa, Tomoaki ;

Okamura, Yasuyoshi ;

Bando, Yukari ;

Furukawa, Junya ;

Harada, Kenichi ;

Nakano, Yuzo ;

Fujisawa, Masato .

PROSTATE, 2023, 83 (13) :1270-1278

← 1 2 →